Biotech IPOs Return as Sector Recovers After Funding Overhang
Healthcare Venture Investors Ante Up. Public Markets Remain Cool. -- Barrons.com
SPDR S&P Biotech ETF Options Spot-On: On September 23rd, 113.56K Contracts Were Traded, With 981.1K Open Interest
On September 23rd ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 113.56K options for the day, of which put options accounted for 51.04% of the total
SPDR S&P Biotech ETF To Go Ex-Dividend On September 23rd, 2024 With 0.01523 USD Dividend Per Share
September 20th (Eastern Time) - $SPDR S&P Biotech ETF(XBI.US)$ is trading ex-dividend on September 23rd, 2024.Shareholders of record on September 23rd, 2024 will receive 0.01523 USD dividend per
SPDR S&P Biotech ETF Options Spot-On: On September 19th, 109.02K Contracts Were Traded, With 1 Million Open Interest
On September 19th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 109.02K options for the day, of which put options accounted for 19.38% of the total
Halozyme Cut to Neutral at J.P. Morgan on Valuation